BGI Genomics Co., Ltd. (SHE:300676)
45.28
-0.43 (-0.94%)
Dec 15, 2025, 10:08 AM CST
BGI Genomics Market Cap
BGI Genomics has a market cap or net worth of 17.55 billion as of December 12, 2025. Its market cap has increased by 0.02% in one year.
Market Cap
17.55B
Enterprise Value
14.65B
Revenue
3.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
45.28
Market Cap Chart
Since July 14, 2017, BGI Genomics's market cap has increased from 7.86B to 17.55B, an increase of 123.28%. That is a compound annual growth rate of 10.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 17.55B | 9.62% |
| Dec 31, 2024 | 16.01B | -18.66% |
| Dec 29, 2023 | 19.68B | -7.14% |
| Dec 30, 2022 | 21.19B | -41.13% |
| Dec 31, 2021 | 35.99B | -29.32% |
| Dec 31, 2020 | 50.92B | 85.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 419.80B |
| WuXi AppTec | 279.36B |
| Shenzhen Mindray Bio-Medical Electronics | 241.66B |
| Sichuan Biokin Pharmaceutical | 148.61B |
| Shanghai United Imaging Healthcare | 105.48B |
| Aier Eye Hospital Group | 103.27B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.09B |
| Yunnan Baiyao Group Co.,Ltd | 99.62B |